🇺🇸 FDA
Pipeline program

N-acetycysteine (600mg twice daily)

KW/EX/09-140

Approved small_molecule completed

Quick answer

N-acetycysteine (600mg twice daily) for COPD is a Approved program (small_molecule) at Kwong Wah Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Kwong Wah Hospital
Indication
COPD
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials